Boué et al. longitudinally assess cognition in patients aged ≥70 years receiving hormone therapy for metastatic prostate cancer. Poorer objective and subjective cognition occurs in patients receiving hormone therapy, particularly when androgen receptor pathway inhibitors (ARPI) are added to androgen deprivation therapy (ADT).
- Antoine Boué
- Giulia Baciarello
- Florence Joly
